Draft:Computational drug discovery
| Submission declined on 3 August 2025 by Aydoh8 (talk). Your draft shows signs of having been generated by a large language model, such as ChatGPT. Their outputs usually have multiple issues that prevent them from meeting our guidelines on writing articles. These include:
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
 | This is a draft article. It is a work in progress open to editing by anyone. Please ensure core content policies are met before publishing it as a live Wikipedia article. Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL Last edited by FarhanaHoqueDS (talk | contribs) 59 minutes ago. (Update)
Finished drafting? or |
Computational drug discovery is an interdisciplinary approach that uses computational methods to identify, design, and optimize potential therapeutic compounds. It plays a critical role in modern drug development by reducing time and cost compared to traditional experimental methods.
Overview
[edit]Computational drug discovery is a multidisciplinary approach that leverages computational technologies and data-driven methods to accelerate and refine the process of discovering new therapeutic agents. This field merges principles from bioinformatics, cheminformatics, molecular modeling, pharmacology, and machine learning and deep learning to analyze biological and chemical data at scale.
Traditionally, drug discovery has been a time-consuming and costly process, involving extensive laboratory experimentation and clinical testing. Computational methods offer a complementary strategy by enabling the in silico prediction of drug behavior, interactions, and efficacy, thus narrowing down the pool of candidate molecules before they enter experimental validation.
Central to computational drug discovery are algorithms and software platforms that simulate various aspects of drug action. These tools are used to:
Predict drug–target interactions by modeling the affinity and specificity of compounds toward biological targets (e.g., proteins, enzymes).
Design and optimize molecular structures using techniques like structure-based drug design (SBDD), ligand-based drug design (LBDD), and de novo design.
Simulate biological systems and dynamics, such as protein folding, binding kinetics, and metabolic pathways, using methods like molecular dynamics and Monte Carlo simulations.
Screen large compound libraries virtually through high-throughput screening and QSAR (Quantitative Structure–Activity Relationship) modeling.
Apply artificial intelligence and machine learning to identify patterns and generate predictive models based on historical biological and chemical data.
By reducing reliance on costly wet-lab experimentation and enabling faster hypothesis testing, computational drug discovery contributes significantly to early-stage pharmaceutical research and precision medicine. The approach has been successfully applied in areas such as oncology, neurodegenerative disorders, infectious diseases, and rare diseases, and continues to evolve with advances in big data, cloud computing, and AI-driven platforms.
Key Techniques
[edit]Computational drug discovery utilizes several key in silico techniques to model, predict, and analyze interactions between chemical compounds and biological targets:
- Molecular docking
Molecular docking simulates the preferred orientation of a small molecule (ligand) when bound to a biological target, such as a protein or enzyme. It helps estimate the binding affinity and structural compatibility of drug–target complexes, guiding hit identification and lead optimization. Common docking tools include AutoDock, Glide, and MOE.[1]
- Quantitative Structure–Activity Relationship (QSAR)
QSAR methods mathematically model the relationship between the chemical structure of compounds and their biological activities. By analyzing a training set of compounds, QSAR models predict the activity of novel molecules based on their descriptors. Machine learning algorithms such as Random Forests, Support Vector Machines, and deep learning are increasingly used to enhance QSAR accuracy.[2]
- Virtual screening (VS)
Virtual screening enables the rapid computational screening of large chemical libraries to identify potential drug candidates. It can be structure-based (e.g., docking-based) or ligand-based (e.g., similarity or pharmacophore-based). Virtual screening significantly reduces the number of compounds requiring experimental testing and is a key component of early-stage drug discovery.[3]
- Pharmacophore modeling
A pharmacophore is a conceptual representation of molecular features essential for biological activity, such as hydrogen bond acceptors/donors, hydrophobic regions, and aromatic rings. Pharmacophore modeling is used to identify or design compounds that match this 3D arrangement, especially when the structure of the target is unknown or partially known.[4]
- Molecular dynamics (MD) simulations
MD simulations provide atomic-level insights into the dynamic behavior of molecules and drug–target complexes over time. They are used to study conformational changes, protein flexibility, binding mechanisms, and solvent effects. Popular MD packages include GROMACS, AMBER, and CHARMM.[5]
These computational techniques can be used individually or integrated in drug discovery pipelines, often in combination with artificial intelligence and high-performance computing platforms to enhance accuracy, speed, and scalability.
Applications
[edit]- Identification of lead compounds
- Drug repurposing
- Toxicity prediction
- Target validation
- Personalized medicine
Advantages
[edit]- Cost-effectiveness
- Speed of hypothesis testing
- Reduction of lab-based trial-and-error
Limitations
[edit]- Reliance on accurate data and algorithms
- Limited prediction accuracy in complex systems
- Challenges in modeling biological variability
References
[edit]- ^ Morris, G. M. (2009). "AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility". Journal of Computational Chemistry. 30: 2785–2791. doi:10.1002/jcc.21256.
- ^ Cherkasov, A. (2014). "QSAR Modeling: Where Have You Been? Where Are You Going To?". Journal of Medicinal Chemistry. 57 (12): 4977–5010. doi:10.1021/jm4004285.
- ^ Shoichet, B. K. (2004). "Virtual screening of chemical libraries". Nature. 432 (7019): 862–865. doi:10.1038/nature03197.
- ^ Schuster, D. (2006). "Pharmacophore modeling and virtual screening: Concepts, software tools, and recent advances". Current Pharmaceutical Design. 12 (2): 181–202. doi:10.2174/138161206775201629.
- ^ Hollingsworth, S. A. (2018). "Molecular dynamics simulation for all". Neuron. 99 (6): 1129–1143. doi:10.1016/j.neuron.2018.08.011.
- Ekins, Sean (2016). "The next era: deep learning in pharmaceutical research". Pharmaceutical Research. 33: 2594–2603. doi:10.1007/s11095-016-2000-2.
- Macalino, Sheryl Joy Y. (2015). "Role of computer-aided drug design in modern drug discovery". Archives of Pharmacal Research. 38 (9): 1686–1701. doi:10.1007/s12272-015-0640-5.
- in-depth (not just passing mentions about the subject)
- reliable
- secondary
- independent of the subject
Make sure you add references that meet these criteria before resubmitting. Learn about mistakes to avoid when addressing this issue. If no additional references exist, the subject is not suitable for Wikipedia.